Arcus Biosciences
RCUS
RCUS
184 hedge funds and large institutions have $1.36B invested in Arcus Biosciences in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $1.33B → $1.36B (+$35.9M)
0.4% less ownership
Funds ownership: 73.13% → 72.73% (-0.4%)
11% less call options, than puts
Call options by funds: $4.87M | Put options by funds: $5.46M
Holders
184
Holding in Top 10
6
Calls
$4.87M
Puts
$5.46M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$17.4M | |
| 3 | +$9.98M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.55M |
Top Sellers
| 1 | -$32.5M | |
| 2 | -$11.1M | |
| 3 | -$10.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.69M |
| 5 |
Morgan Stanley
New York
|
-$6.03M |